Investigating the Relationship between Serum Interleukin-17 Levels and Systemic Immune-Mediated Disease in Patients with Dry Eye Syndrome
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Purpose: To investigate the association between dry eye syndrome (DE) and serum levels of interleukin (IL)-17 in patients with systemic immune-mediated diseases. Methods: IL-17 and IL-23 levels were measured in the sera of patients whose tear production was <5 mm on the Schirmer test. Subjects included patients with chronic graft-versus-host disease (GVHD), rheumatoid arthritis (RA), Sjogren’s syndrome (SS), systemic lupus erythematosus (SLE), and no systemic disease. Corneal/conjunctival fluorescein staining was scored and the correlation between the score and the IL-17 level was evaluated. Results: A strong correlation existed between IL-17 level and the type of systemic disease. IL-17 was significantly elevated in patients with chronic GVHD compared to those with RA and SS. IL-17 was not detectable in patients with SLE or in those without systemic disease. IL-23 was not detected in any of the subjects. IL-17 was significantly increased in patients with high fluorescein staining scores. Conclusions: Our data suggest that IL-17 is involved in the pathogenesis of DE in patients with systemic immune-mediated diseases.
Abstract
Purpose: To investigate the association between dry eye syndrome (DE) and serum levels of interleukin (IL)-17 in patients with systemic immune-mediated diseases. Methods: IL-17 and IL-23 levels were measured in the sera of patients whose tear production was <5 mm on the Schirmer test. Subjects included patients with chronic graft-versus-host disease (GVHD), rheumatoid arthritis (RA), Sjogren’s syndrome (SS), systemic lupus erythematosus (SLE), and no systemic disease. Corneal/conjunctival fluorescein staining was scored and the correlation between the score and the IL-17 level was evaluated. Results: A strong correlation existed between IL-17 level and the type of systemic disease. IL-17 was significantly elevated in patients with chronic GVHD compared to those with RA and SS. IL-17 was not detectable in patients with SLE or in those without systemic disease. IL-23 was not detected in any of the subjects. IL-17 was significantly increased in patients with high fluorescein staining scores. Conclusions: Our data suggest that IL-17 is involved in the pathogenesis of DE in patients with systemic immune-mediated diseases.
참고문헌 (18)
- Nguyen CQ, "Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjogren’s syndrome:findings in humans and mice", Arthritis Rheum, 58, pp.734~743 (2008)
- Sakai A, "Identification of IL-18 and Th17 cells in salivary glands of patients with Sjogren’s syndrome,and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18", J Immunol, 181, pp.2898~2906 (2008)
- Garrett-Sinha LA, "IL-17 and the Th17 lineage in systemic lupus erythematosus", Curr Opin Rheumatol, 20, pp.519~525 (2008)
- Tesmer LA, "Th17 cells in human disease", Immunol Rev, 223, pp.87~113 (2008)
- Chi W, "Upregulated IL-23 and IL-17 in Behcet patients with active uveitis", Invest Ophthalmol Vis Sci, 49, pp.3058~3064 (2008)
- Amadi-Obi A, "TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27", STAT1, 2007, pp.13, 711~718
- Abraham C, "Interleukin-23", Th17 pathways and inflammatory bowel disease, 2009, pp.15, 1090~1100
- Diveu C, "Cytokines that regulate autoimmunity", Curr Opin Immunol, 20, pp.663~668 (2008)
- McGeachy MJ, "The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo", Nat Immunol, 10, pp.314~324 (2009)
- Langrish CL, "IL-23 drives a pathogenic T cell population that induces autoimmune inflammation", J Exp Med, 201, pp.233~240 (2005)
- Yen D, "IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6", J Clin Invest, 116, pp.1310~1316 (2006)
- Murphy CA, "Divergent pro-and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation", J Exp Med, 198, pp.1951~1957 (2003)
- Norn MS, "Lissamine green.Vital staining of cornea and conjunctiva", Acta Ophthalmol(Copenh), 51, pp.483~491 (1973)
- Kappel LW, "IL-17 contributes to CD4-mediated graft-versus-host disease", Blood, 113, pp.945~952 (2009)
- De Paiva CS, "IL-17 disrupts corneal barrier following desiccating stress", Mucosal Immunol, 2, pp.243~253 (2009)
- Sutton CE, "Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells,amplifying Th17 responses and autoimmunity", Immunity, 31, pp.331~341 (2009)
- Mathers WD, "Why the eye becomes dry:a cornea and lacrimal gland feedback model", CLAO J, 26, pp.159~165 (2000)
- Chauhan SK, "Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression", J Immunol, 182, pp.1247~1252 (2009)